Everett Neville Sells 175 Shares of Cigna Co. (NYSE:CI) Stock

Cigna Co. (NYSE:CI) EVP Everett Neville sold 175 shares of the company’s stock in a transaction dated Tuesday, January 11th. The stock was sold at an average price of $240.00, for a total value of $42,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Everett Neville also recently made the following trade(s):

  • On Monday, January 3rd, Everett Neville sold 4,800 shares of Cigna stock. The shares were sold at an average price of $229.49, for a total value of $1,101,552.00.

Cigna stock opened at $242.17 on Friday. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $80.26 billion, a P/E ratio of 10.18, a PEG ratio of 0.96 and a beta of 0.91. The stock’s 50 day moving average is $219.15 and its 200 day moving average is $216.96. Cigna Co. has a twelve month low of $191.74 and a twelve month high of $272.81.

Cigna (NYSE:CI) last posted its quarterly earnings results on Thursday, November 4th. The health services provider reported $5.73 earnings per share for the quarter, topping the consensus estimate of $5.23 by $0.50. The company had revenue of $44.30 billion for the quarter, compared to the consensus estimate of $42.88 billion. Cigna had a return on equity of 13.72% and a net margin of 4.93%. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.41 EPS. As a group, equities analysts expect that Cigna Co. will post 20.41 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 22nd. Shareholders of record on Tuesday, December 7th were paid a dividend of $1.00 per share. The ex-dividend date was Monday, December 6th. This represents a $4.00 annualized dividend and a yield of 1.65%. Cigna’s dividend payout ratio is 16.81%.

A number of equities research analysts have recently weighed in on the company. Seaport Res Ptn reissued a “buy” rating on shares of Cigna in a research note on Wednesday, November 17th. Jefferies Financial Group boosted their target price on Cigna from $270.00 to $277.00 and gave the company a “buy” rating in a research note on Friday, November 5th. BMO Capital Markets lowered their target price on Cigna from $300.00 to $275.00 and set an “outperform” rating for the company in a research note on Monday, November 8th. Truist boosted their target price on Cigna from $270.00 to $275.00 in a research note on Wednesday, January 5th. Finally, Mizuho lowered their target price on Cigna from $267.00 to $245.00 and set a “buy” rating for the company in a research note on Monday, December 20th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Cigna has an average rating of “Buy” and a consensus target price of $262.04.

Institutional investors and hedge funds have recently modified their holdings of the business. Samalin Investment Counsel LLC bought a new position in shares of Cigna during the 2nd quarter valued at $29,000. Financial Insights Inc. bought a new position in shares of Cigna during the 2nd quarter valued at $31,000. Liberty Wealth Management LLC lifted its holdings in shares of Cigna by 19,515.4% during the 2nd quarter. Liberty Wealth Management LLC now owns 7,650 shares of the health services provider’s stock valued at $32,000 after buying an additional 7,611 shares during the period. Wolff Wiese Magana LLC lifted its holdings in shares of Cigna by 203.7% during the 3rd quarter. Wolff Wiese Magana LLC now owns 164 shares of the health services provider’s stock valued at $33,000 after buying an additional 110 shares during the period. Finally, Tompkins Financial Corp bought a new position in shares of Cigna during the 3rd quarter valued at $38,000. Institutional investors and hedge funds own 86.34% of the company’s stock.

About Cigna

Cigna Corp. engages in the provision of global health services. It operates through the following segments: Evernorth, U.S. Medical, International Markets, and Group Disability and Other. The Evernorth segment includes a broad range of coordinated and point solution health services, including pharmacy solutions, benefits management solutions, care solutions and intelligence solutions.

Featured Story: What are high-yield dividend stocks?

Insider Buying and Selling by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.